The prediabetic problem: Development of non-insulin-dependent diabetes mellitus and related abnormalities

Journal of Diabetes and its Complications

Volumn 11, Issue 2, 1997, Pages 69-76

  Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; PREDIABETIC STATE; RISK FACTORS;

EID: 0030893106     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00099-2     Document Type: Article

References (106)

1. Center for Economic Studies in Medicine: Direct and Indirect Cost of Diabetes in the United States in 1987. Alexandria, VA, American Diabetes Association, 1988.
2. Marks HH, Krall LP: Onset, course, prognosis, and mortality in diabetes mellitus, In Marble A, White P, Bradley RF (eds), Joslin's Diabetes Mellitus, 11th ed. Philadelphia, Lea and Febiger, pp. 227-228, 1971.
3. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: An epidemiologic view. Diabetes 3:463-524, 1987.
4. Dunn FL: Hyperlipidemia in diabetes mellitus. Diabetes 6:47-61, 1990.
5. Stern MP, Haffner SM: Dyslipidemia in type II diabetes: Implications for therapeutic intervention. Diabetes Care 14:1144-1159, 1991.
6. Jarrett RJ: Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 5:547-558, 1989.
7. Stout RW: Insulin and atheroma: 20-yr. perspective. Diabetes Care 13:631-654, 1990.
8. Merrin PK, Feher MD, Elkeles RS: Diabetic macrovascular disease and serum lipids: Is there a connection? Diabetic Med 9:914, 1992.
9. Wingard D, Barrett-Connor E. Heart disease and diabetes, in Harris MI, (eds): Diabetes in America, NIH Publication No. 95-1468. Bethesda, MD, National Institutes of Health, pp. 429-448, 1995.
10. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988.
11. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 2:120-126, 1979.
12. Barrett-Connor E, Wingard DL: Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 118:489-496, 1983.
13. Heyden S, Heiss G, Bartel AG, Hames CG: Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265-273, 1980.
14. Entmacher PS, Root HF, Marks HH: Longevity of diabetic patients in recent years. Diabetes 13:373-377, 1964.
15. Westlund, K: Mortality of diabetics. Life Insurance Companies Institute for Medical Statistics at the Oslo City Hospital, report no. 13, Universitetsforlaget, 1969.
16. Herman JB, Medalie JH, Goldbourt U: Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia 13:229-234, 1977.
17. Jarrett RJ, McCartney P, Keen H: The Bedford study: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics. Diabetologia 22:79-84, 1982.
18. Head J, Fuller JH: International variation in mortality among diabetic patients: The WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33:477-481, 1990.
19. Butler WJ, Ostrander LD Jr., Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh Study: Long term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 121:541-547, 1985.
20. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987.
21. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Liebow IM, Howard BV, Bennett PH: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990.
22. Pan W-H, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986.
23. Zimmet PZ, Finch CF, Schooneveldt MG, King HO, Thoma K: Mortality from diabetes in Nauru. Results of 4-yr. follow-up. Diabetes Care 11:305-310, 1988.
24. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin JE: Hypertriglyceridemia as a risk factor for coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989.
25. Jarrett RJ, Shipley MJ: Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease - putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia 31:737-740, 1988.
26. Barrett-Connor E, Wingard DL: Sex differential in schemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 118: 489-496, 1983.
27. Laakso M, Rönnemaa T, Lehto S, Pukka P, Kallio V, Pyörälä K: Does NIDDM increase the risk for coronary heart disease similarly in low and high risk populations? Diabetologia 38:487-493, 1995.
28. Kannell WB, Hjortland M, Castelli WP: Role of diabetes in cardiac disease: Conclusions from population studies. The Framingham Study. Am J Cardiol 34:29-34, 1974.
29. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM: Clinical features of unrecognized myocardial infarction-silent and symptomatic. Eighteen year follow-up: The Framingham Study. Am J Cardiol 32:1-7, 1973.
30. Królewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset insult-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987.
31. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151:1141-1147, 1991.
32. Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham Study. JAMA 241:2035-2038, 1979.
33. Rewers M, Shetterly SM, Baxter J: Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): The San Luis Valley Diabetes Study [Abstract]. Circulation 85:4, 1995.
34. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in noninsulin-dependent diabetic and non-diabetic subjects. Circulation 82:27-36, 1990.
35. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: A general population study. BMJ 299:1127-1131, 1989.
36. Lapidus L, Bengtsson C, Blohme G, Lindquist O, Nystrom E: Blood glucose, glucose tolerance and manifest diabetes in relation to cardiovascular disease and death in women. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 218:455-462, 1985.
37. Palumbo PJ, Elveback LR, Connolly DC: Coronary heart disease in the diabetic: Epidemiological aspects. The Rochester Diabetes Project, in Scott RC (ed), Clinical Cardiology and Diabetes, vol 1. Mount Kisco, NY, Futura, 1987, pp. 13-27.
38. Diabetes Drafting Group: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetologia 28:615-640, 1985.
39. Ballard DJ, Melton LJ, Dwyer MS, Trautmann JC, Chu CP, O'Fallon WM, Palumbo PJ: Risk factors for diabetic retinopathy. A population-based study in Rochester, Minnesota. Diabetes Care 9:334-342, 1986.
40. Klein R, Klein BEK, Moss SE, Davis MD, Demets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988.
41. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ: Chronic renal failure in non-insulin dependent diabetes mellitus: A population-based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989.
42. Pugh JA: The epidemiology of diabetic nephropathy. Diabetes Metab Rev 5:531-545, 1989.
43. West KM, Ahuja MMS, Bennett PH, Czyzyk A, De Acosta DM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:361-369, 1983.
44. Nielsen NV, Ditzel J: Prevalence of macro-and microvascular disease as related to glycosylated hemoglobin in type I and type II diabetic subjects: An epidemiologic study in Denmark. Horm Metab Res Suppl 15:19-23, 1985.
45. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study. Lancet 1:1373-1376, 1980.
46. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H: A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors. Diabetalogia 33:542-548, 1990.
47. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994.
48. Laakso M, Lehto S, Penttilä I, Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993.
49. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H: Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438, 1993.
50. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91:9441-9445, 1994.
51. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet 1:1356-1359, 1989.
52. Sicree RA, Zimmet PZ, King HOM, Coventry JS: Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 years. Diabetes 36:179-186, 1987.
53. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 39:283-288, 1990.
54. Hamman RF: Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287-338, 1992.
55. Bergstrom W, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990.
56. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E: Risk factors for NIDDM in white populations: Paris Prospective Study. Diabetes 40:796-799, 1991.
57. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M: Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553-559, 1993.
58. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915, 1990.
59. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993.
60. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978.
61. Stern MP, Gaskill SP, Hazuda HP, Gardner LI, Haffner SM: Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia 24:272-277, 1983.
62. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods/and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989.
63. Aronoff SL, Bennett PH, Gorden P, Rushforth N, Miller M: Unexplained hyperinsulinemia in normal and "prediabetic" Pima Indians compared with normal Caucasians: an example of racial differences in insulin secretion. Diabetes 26:827-840, 1977.
64. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 315:220-224, 1986.
65. Haffner SM, Bowsher RR, Mykkänen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, Stern MP: Proinsulin and specific insulin concentrations in high and low risk for non-insulin dependent diabetes mellitus. Diabetes 43:1490-1493, 1994.
66. Boyko EJ, Keane EM, Marshall JA, Hamman RF: Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. Diabetes 40:509-515, 1991.
67. Nagulesparan M, Savage PJ, Knowler WC, Johnson GC, Bennett PH: Increased in vivo insulin resistance in non-diabetic Pima Indians compared with Caucasians. Diabetes 31:952-956, 1982.
68. Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN: Diminished insulin sensitivity and increased insulin response in non-obese, in non-diabetic Mexican Americans. Metabolism 39:842-847, 1990.
69. Harris MI: Non-insulin dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 6:71-90, 1990.
70. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989.
71. Osei K, Cottrell DA, Adenuwon CA, Ezenwaka EC, Akanji AO, O'Dorisio TM: Serum insulin and glucose concentrations in people at risk for type II diabetes: A comparative study of African Americans and Nigerians. Diabetes Care 16:1367-1375, 1993.
72. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared to non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996.
73. Mykkänen L, Kuusisto J, Hales CN, Pyörälä K, Laakso M, Haffner SM: Serum proinsulin levels are dispropor-tionately increased in elderly prediabetic subjects. Diabetologia 38:1328-1336, 1995.
74. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese American men. Diabetes 44:173-179, 1995.
75. Reaven GM: 1988 Banting Lecture: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
76. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin dependent diabetes mellitus in a community of order adults. Am J Epidemiol 131:443-453, 1990.
77. Medalie JH, Papier CM, Goldbourt U, Herman JB: Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135:811-817, 1975.
78. Pell S, D'Alonzo CA: Some aspects of hypertension in diabetes mellitus. JAMA 202:104-110, 1975.
79. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990.
80. Haffner SM, Miettinen H: Relatively more atherogenic coronary heart disease risk factors in prediabetic women in prediabetic men. Diabetes 45 (suppl. 1), 1996.
81. Waiden CE, Knopp RH, Wahl PW, Beach KW, Strandness EJ: Sex differences in the effect of diabetes mellitus on lipoprotein triglycride and cholesterol concentrations. N Engl J Med 311:953-959, 1984.
82. Stern MP, Mitchell BD, Haffner SM, Hazuda HP: Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective. Diabetes Care 15:638-644, 1992.
83. Assmann G, Schulte H: The Prospective Cardiovascular Munster (PROCAM) Study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and their relationship to coronary heart disease. Am Heart J 116:1713-1724, 1988.
84. Laakso M, Barrett Connor LE: Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 9:665-672, 1989.
85. Falko JM, Parr JH, Simpson RN, Wynn V: Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med 83:641-647, 1987.
86. Briones ER, Mao SJT, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA: Analyses of plasma lipids and apolipoproteins in insulin-dependent and non-insulindependent diabetics. Metabolism 33:42-49, 1984.
87. Crouse JR, Parks JS, Schey HM, Kahl FR.-Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985.
88. Austin MA, Breslow JL, Heinekens CHD, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988.
89. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis 12:187-195, 1992.
90. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990.
91. McNamara JR, Campos H, Ordovas JM, Peterson RM, Wilson PWF, Schaefer EJ: Effect of gender, age and lipid status on low density subfraction distribution: results of the Framingham Offspring Study. Arteriosclerosis 7:483-490, 1987.
92. Swinkels DW, Demacker PNM, Hendricks JCM, Van't Laar A: Low density lipoprotein subfractions and relationship of other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9:604-613, 1989.
93. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 85:381-387, 1993.
94. Campos H, Willett WC, Peterson RM, Sues X, Bailey SM, Wilson PWF, Posner BM, Ordovas JM, Schaefer EJ: Nutrient intake comparisons between Framingham and urban Costa Rica: associations with lipids, lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb 11:1089-1099, 1991.
95. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM: Insulin resistance in individuals with small, dense lipoprotein particles. J Clin Invest 92:141-146, 1993.
96. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV. LDL size and subclass pattern in a biethnic population. Arteriosclerosis 13:1623-1630, 1993.
97. Feingold KR, Grunfeld C, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Arteriosder Thromb 12:1496-1502, 1992.
98. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164-1171, 1994.
99. Austin MA, Mykkänen L, Kuusisto J, Edwards KL Nelson CL, Haffner SM, Pyörälä K, Laakso M: Prospective study of small LDLs as a risk for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 92:1770-1778, 1995.
100. Bengtsson C, Blohme G, Lapidus L, Linquist O, Lundgren H, Nystrom E, Peterson K, Sigurdsson JA: Do antihypertensive drugs precipitate diabetes? BMJ 298:1147-1152, 1989.
101. Skafors ET, Lithell HO, Selinus I, Aberg H: Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ 289:1147-1152, 1989.
102. Murphy MB, Lewis PJ, Kohner E, Schurner B, Dollery CT: Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up. Lancet ii:1293-1295, 1982.
103. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffher SM: Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects: the San Antonio Heart Study. Diabetes 42:154-161, 1993.
104. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M, Haffner SM: Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 12:1425-1432, 1994.
105. Lithell H: Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 14:203-209, 1991.
106. Gurwitz JH, Bohn RJ, Glynn RJ, Monane M, Mogun H, Avorn J: Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med 118:273-278, 1993.